The Cooper Companies, Inc. (COO) EV/EBITDA Ratio: 17.97x
Is The Cooper Companies, Inc.’s EV/EBITDA ratio high or low?
The Cooper Companies, Inc.'s EV/EBITDA ratio of 17.97x is 18% below its 5-year average of 21.92x, near the low end of its 5-year range (13.19x–31.93x).
As of Sunday, June 14, 2026. 12.64% above its 12-month average of 15.95x.
COO EV/EBITDA Ratio Chart
COO Average EV/EBITDA Ratio Chart
COO Current vs Average EV/EBITDA Ratio Chart
COO EV/EBITDA Ratio Metrics
EV/EBITDA RATIO
17.97x
EV/EBITDA RATIO AVG TTM
15.95x
EV/EBITDA RATIO AVG 3Y
20.14x
EV/EBITDA RATIO AVG 5Y
21.92x
EV/EBITDA RATIO AVG 10Y
22.78x
EV/EBITDA RATIO AVG 15Y
20.62x
EV/EBITDA RATIO AVG 20Y
18.50x
CURRENT VS TTM AVG
+12.64%
CURRENT VS 3Y AVG
-10.76%
CURRENT VS 5Y AVG
-18.02%
CURRENT VS 10Y AVG
-21.11%
CURRENT VS 15Y AVG
-12.84%
CURRENT VS 20Y AVG
-2.85%
COO Competitors' EV/EBITDA Ratio
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| The Cooper Companies, Inc. (COO) | $13.24B | 17.97x | 15.95x | 20.14x | 21.92x |
| Solventum Corporation (SOLV) | $13.66B | 6.67x | 10.13x | 10.29x | 10.29x |
| Align Technology, Inc. (ALGN) | $12.52B | 13.57x | 13.18x | 20.32x | 25.99x |
| Baxter International Inc. (BAX) | $10.77B | 24.95x | 20.34x | 19.12x | 19.11x |
| Walgreens Boots Alliance, Inc. (WBA) | $10.37B | N/A | 21.34x | 19.40x | 19.09x |
| Hologic, Inc. (HOLX) | $16.97B | 17.28x | 15.01x | 15.35x | 12.41x |
| Charles River Laboratories International, Inc. (CRL) | $9.03B | 41.45x | 24.46x | 17.37x | 18.48x |
| Tempus AI, Inc. (TEM) | $8.35B | N/A | N/A | N/A | N/A |
| Bio-Rad Laboratories, Inc. (BIO) | $7.73B | 18.27x | 11.86x | 62.18x | 32.77x |
| Moderna, Inc. (MRNA) | $19.80B | N/A | 12.39x | 25.28x | 25.28x |
EV/EBITDA vs. its own history
At 18.0, EV/EBITDA is in its normal range, sitting higher than 44% of its 20-year history.
20-year low
6.7
median
19.5
20-year high
36.3
The Cooper Companies, Inc. EV/EBITDA Ratio Formula & Definition
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
The Cooper Companies, Inc. EV/EBITDA Ratio FAQ
- What is the EV/EBITDA ratio for The Cooper Companies, Inc. (COO)?
- The EV/EBITDA ratio for COO stock is 17.97x.
- Is The Cooper Companies, Inc.'s EV/EBITDA ratio high or low?
- The Cooper Companies, Inc.'s EV/EBITDA ratio of 17.97x is 18% below its 5-year average of 21.92x, near the low end of its 5-year range (13.19x–31.93x).
- What is the TTM average EV/EBITDA ratio for The Cooper Companies, Inc. (COO)?
- The TTM average EV/EBITDA ratio for COO stock is 15.95x.
- What is the 3Y average EV/EBITDA ratio for The Cooper Companies, Inc. (COO)?
- The 3Y average EV/EBITDA ratio for COO stock is 20.14x.
- What is the 5Y average EV/EBITDA ratio for The Cooper Companies, Inc. (COO)?
- The 5Y average EV/EBITDA ratio for COO stock is 21.92x.
- What is the 10Y average EV/EBITDA ratio for The Cooper Companies, Inc. (COO)?
- The 10Y average EV/EBITDA ratio for COO stock is 22.78x.
- What is the 15Y average EV/EBITDA ratio for The Cooper Companies, Inc. (COO)?
- The 15Y average EV/EBITDA ratio for COO stock is 20.62x.
- What is the 20Y average EV/EBITDA ratio for The Cooper Companies, Inc. (COO)?
- The 20Y average EV/EBITDA ratio for COO stock is 18.50x.
The Cooper Companies, Inc. EV/EBITDA Ratio History
| DATE | EV/EBITDA RATIO |
|---|---|
| 2026-06-12 | 17.97x |
| 2026-06-11 | 17.88x |
| 2026-06-10 | 17.92x |
| 2026-06-09 | 18.13x |
| 2026-06-08 | 17.72x |
| 2026-06-05 | 17.85x |
| 2026-06-04 | 13.76x |
| 2026-06-03 | 13.45x |
| 2026-06-02 | 13.29x |
| 2026-06-01 | 13.42x |
| 2026-05-29 | 13.61x |
| 2026-05-28 | 13.58x |
| 2026-05-27 | 13.53x |
| 2026-05-26 | 13.76x |
| 2026-05-22 | 13.86x |
| 2026-05-21 | 13.91x |
| 2026-05-20 | 13.71x |
| 2026-05-19 | 13.65x |
| 2026-05-18 | 13.56x |
| 2026-05-15 | 13.31x |
| 2026-05-14 | 13.45x |
| 2026-05-13 | 13.28x |
| 2026-05-12 | 13.37x |
| 2026-05-11 | 13.19x |
| 2026-05-08 | 13.38x |
| 2026-05-07 | 13.59x |
| 2026-05-06 | 13.59x |
| 2026-05-05 | 13.62x |
| 2026-05-04 | 13.67x |
| 2026-05-01 | 13.82x |
| 2026-04-30 | 13.92x |
| 2026-04-29 | 13.63x |
| 2026-04-28 | 13.96x |
| 2026-04-27 | 14.19x |
| 2026-04-24 | 14.20x |
| 2026-04-23 | 14.30x |
| 2026-04-22 | 14.67x |
| 2026-04-21 | 14.74x |
| 2026-04-20 | 15.14x |
| 2026-04-17 | 15.25x |
| 2026-04-16 | 15.12x |
| 2026-04-15 | 15.29x |
| 2026-04-14 | 15.54x |
| 2026-04-13 | 15.56x |
| 2026-04-10 | 15.46x |
| 2026-04-09 | 15.51x |
| 2026-04-08 | 15.56x |
| 2026-04-07 | 15.18x |
| 2026-04-06 | 15.29x |
| 2026-04-02 | 15.27x |
| 2026-04-01 | 15.51x |
| 2026-03-31 | 15.52x |
| 2026-03-30 | 15.11x |
| 2026-03-27 | 15.20x |
| 2026-03-26 | 15.53x |
| 2026-03-25 | 15.51x |
| 2026-03-24 | 15.33x |
| 2026-03-23 | 15.28x |
| 2026-03-20 | 15.23x |
| 2026-03-19 | 15.37x |
| 2026-03-18 | 15.46x |
| 2026-03-17 | 15.62x |
| 2026-03-16 | 15.43x |
| 2026-03-13 | 15.23x |
| 2026-03-12 | 15.52x |
| 2026-03-11 | 15.94x |
| 2026-03-10 | 16.06x |
| 2026-03-09 | 16.32x |
| 2026-03-06 | 16.46x |
| 2026-03-05 | 18.21x |
| 2026-03-04 | 18.55x |
| 2026-03-03 | 18.82x |
| 2026-03-02 | 18.93x |
| 2026-02-27 | 18.88x |
| 2026-02-26 | 18.95x |
| 2026-02-25 | 18.84x |
| 2026-02-24 | 18.86x |
| 2026-02-23 | 18.74x |
| 2026-02-20 | 18.96x |
| 2026-02-19 | 18.88x |
| 2026-02-18 | 18.83x |
| 2026-02-17 | 18.54x |
| 2026-02-13 | 18.75x |
| 2026-02-12 | 18.50x |
| 2026-02-11 | 18.76x |
| 2026-02-10 | 18.47x |
| 2026-02-09 | 18.45x |
| 2026-02-06 | 18.57x |
| 2026-02-05 | 18.19x |
| 2026-02-04 | 18.35x |
| 2026-02-03 | 18.04x |
| 2026-02-02 | 18.29x |
| 2026-01-30 | 18.43x |
| 2026-01-29 | 18.24x |
| 2026-01-28 | 18.26x |
| 2026-01-27 | 18.30x |
| 2026-01-26 | 18.34x |
| 2026-01-23 | 18.42x |
| 2026-01-22 | 18.71x |
| 2026-01-21 | 18.66x |
| 2026-01-20 | 18.29x |
| 2026-01-16 | 18.63x |
| 2026-01-15 | 18.62x |
| 2026-01-14 | 18.50x |
| 2026-01-13 | 18.50x |
| 2026-01-12 | 18.79x |
| 2026-01-09 | 18.84x |
| 2026-01-08 | 18.77x |
| 2026-01-07 | 18.92x |
| 2026-01-06 | 19.01x |
| 2026-01-05 | 18.70x |
| 2026-01-02 | 18.38x |
| 2025-12-31 | 18.55x |
| 2025-12-30 | 18.65x |
| 2025-12-29 | 18.59x |
| 2025-12-26 | 18.68x |
| 2025-12-24 | 18.67x |
| 2025-12-23 | 18.73x |
| 2025-12-22 | 18.91x |
| 2025-12-19 | 18.70x |
| 2025-12-18 | 18.64x |
| 2025-12-17 | 18.65x |
| 2025-12-16 | 18.37x |
| 2025-12-15 | 18.46x |
| 2025-12-12 | 18.57x |
| 2025-12-11 | 18.58x |
| 2025-12-10 | 18.31x |
| 2025-12-09 | 17.88x |
| 2025-12-08 | 17.79x |
| 2025-12-05 | 18.44x |
| 2025-12-04 | 16.32x |
| 2025-12-03 | 16.13x |
| 2025-12-02 | 16.10x |
| 2025-12-01 | 16.39x |
| 2025-11-28 | 16.49x |
| 2025-11-26 | 16.49x |
| 2025-11-25 | 16.54x |
| 2025-11-24 | 16.13x |
| 2025-11-21 | 16.04x |
| 2025-11-20 | 15.23x |
| 2025-11-19 | 15.42x |
| 2025-11-18 | 15.43x |
| 2025-11-17 | 15.28x |
| 2025-11-14 | 15.42x |
| 2025-11-13 | 15.35x |
| 2025-11-12 | 15.49x |
| 2025-11-11 | 15.35x |
| 2025-11-10 | 15.16x |
| 2025-11-07 | 15.05x |
| 2025-11-06 | 14.85x |
| 2025-11-05 | 14.82x |
| 2025-11-04 | 14.86x |
| 2025-11-03 | 15.00x |
| 2025-10-31 | 15.01x |
| 2025-10-30 | 15.05x |
| 2025-10-29 | 14.95x |
| 2025-10-28 | 15.35x |
| 2025-10-27 | 15.55x |
| 2025-10-24 | 15.67x |
| 2025-10-23 | 15.86x |
| 2025-10-22 | 15.85x |
| 2025-10-21 | 15.95x |
| 2025-10-20 | 15.95x |
| 2025-10-17 | 15.39x |
| 2025-10-16 | 15.32x |
| 2025-10-15 | 14.80x |
| 2025-10-14 | 15.25x |
| 2025-10-13 | 14.90x |
| 2025-10-10 | 14.73x |
| 2025-10-09 | 14.98x |
| 2025-10-08 | 15.08x |
| 2025-10-07 | 14.85x |
| 2025-10-06 | 15.05x |
| 2025-10-03 | 15.11x |
| 2025-10-02 | 14.87x |
| 2025-10-01 | 14.67x |
| 2025-09-30 | 14.76x |
| 2025-09-29 | 14.60x |
| 2025-09-26 | 14.58x |
| 2025-09-25 | 14.46x |
| 2025-09-24 | 14.73x |
| 2025-09-23 | 14.57x |
| 2025-09-22 | 14.66x |
| 2025-09-19 | 14.69x |
| 2025-09-18 | 14.52x |
| 2025-09-17 | 13.98x |
| 2025-09-16 | 14.14x |
| 2025-09-15 | 14.20x |
| 2025-09-12 | 14.42x |
| 2025-09-11 | 14.75x |
| 2025-09-10 | 14.60x |
| 2025-09-09 | 14.71x |
| 2025-09-08 | 14.81x |
| 2025-09-05 | 14.68x |
| 2025-09-04 | 14.66x |
| 2025-09-03 | 14.50x |
| 2025-09-02 | 14.17x |
| 2025-08-29 | 14.55x |
| 2025-08-28 | 14.03x |
| 2025-08-27 | 15.78x |
| 2025-08-26 | 15.69x |
| 2025-08-25 | 15.66x |
| 2025-08-22 | 15.98x |
| 2025-08-21 | 15.58x |
| 2025-08-20 | 15.66x |
| 2025-08-19 | 15.76x |
| 2025-08-18 | 15.67x |
| 2025-08-15 | 15.62x |
| 2025-08-14 | 15.65x |
| 2025-08-13 | 15.80x |
| 2025-08-12 | 15.52x |
| 2025-08-11 | 15.19x |
| 2025-08-08 | 15.08x |
| 2025-08-07 | 14.88x |
| 2025-08-06 | 14.68x |
| 2025-08-05 | 14.94x |
| 2025-08-04 | 15.29x |
| 2025-08-01 | 15.18x |
| 2025-07-31 | 15.15x |
| 2025-07-30 | 15.44x |
| 2025-07-29 | 15.70x |
| 2025-07-28 | 15.56x |
| 2025-07-25 | 15.86x |
| 2025-07-24 | 15.72x |
| 2025-07-23 | 15.64x |
| 2025-07-22 | 15.58x |
| 2025-07-21 | 15.27x |
| 2025-07-18 | 15.50x |
| 2025-07-17 | 15.62x |
| 2025-07-16 | 15.52x |
| 2025-07-15 | 15.43x |
| 2025-07-14 | 15.68x |
| 2025-07-11 | 15.90x |
| 2025-07-10 | 16.25x |
| 2025-07-09 | 15.93x |
| 2025-07-08 | 15.80x |
| 2025-07-07 | 15.63x |
| 2025-07-03 | 15.63x |
| 2025-07-02 | 15.58x |
| 2025-07-01 | 15.54x |
| 2025-06-30 | 15.24x |
| 2025-06-27 | 15.23x |
| 2025-06-26 | 14.97x |
| 2025-06-25 | 14.94x |
| 2025-06-24 | 15.19x |
| 2025-06-23 | 14.94x |
| 2025-06-20 | 14.93x |
| 2025-06-18 | 14.99x |
| 2025-06-17 | 14.80x |
| 2025-06-16 | 14.98x |
| 2025-06-13 | 14.97x |
| 2025-06-12 | 15.19x |
| 2025-06-11 | 15.28x |
| 2025-06-10 | 15.52x |
| 2025-06-09 | 15.38x |
| 2025-06-06 | 15.45x |
| 2025-06-05 | 15.24x |
| 2025-06-04 | 14.55x |
| 2025-06-03 | 14.46x |
| 2025-06-02 | 14.48x |
Showing the most recent 260 of 5,033 data points. The chart above shows the full history.
Related Metrics
About The Cooper Companies, Inc.
The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Albert G. White